Jury Awards Boehringer $7M In Patent Suit Vs. Schering-Plough

Law360, New York (June 3, 2004, 12:00 AM EDT) -- A federal jury has awarded Boehringer-Ingelheim $7 million plus interest in its patent lawsuit against Schering-Plough Corp. over swine vaccines.

The jury in the U.S. District Court for the District of New Jersey awarded the amount based on a prior decision finding infringement of a Boehringer-Ingelheim patent in 2000, according to Schering-Plough.

The jury found that the Schering-Plough’s PRIME PAC PRRS (Porcine Respiratory and Reproductive Syndrome) vaccine infringed a patent owned by Boehringer-Ingelheim Vetmedica, Inc.

Boehringer-Ingelheim’s patent covers a vaccine for PRRS, a major killer of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.